|
Name |
Diaporthichalasin A
|
Molecular Formula | C28H37NO4 | |
IUPAC Name* |
(1R,2R,3E,5S,7S,9E,11R,12S,14S,15R,16S)-2,12-dihydroxy-16-[(3-hydroxyphenyl)methyl]-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2([C@@H](/C=C/[C@H](C1)C)O)C(=O)N[C@H]3CC4=CC(=CC=C4)O)C)O
|
|
InChI |
InChI=1S/C28H37NO4/c1-16-7-5-10-22-26(32)19(4)18(3)25-23(15-20-8-6-9-21(30)14-20)29-27(33)28(22,25)24(31)12-11-17(2)13-16/h5-6,8-12,14,16-18,22-26,30-32H,4,7,13,15H2,1-3H3,(H,29,33)/b10-5+,12-11+/t16-,17+,18+,22-,23-,24+,25-,26+,28+/m0/s1
|
|
InChIKey |
YXIVMDRKVLWTLF-SCHSUBQJSA-N
|
|
Synonyms |
Diaporthichalasin A
|
|
CAS | NA | |
PubChem CID | 146683412 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 451.6 | ALogp: | 3.9 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.501 |
Caco-2 Permeability: | -5.368 | MDCK Permeability: | 0.00000813 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.991 |
Human Intestinal Absorption (HIA): | 0.428 | 20% Bioavailability (F20%): | 0.807 |
30% Bioavailability (F30%): | 0.305 |
Blood-Brain-Barrier Penetration (BBB): | 0.133 | Plasma Protein Binding (PPB): | 80.46% |
Volume Distribution (VD): | 0.659 | Fu: | 3.46% |
CYP1A2-inhibitor: | 0.108 | CYP1A2-substrate: | 0.131 |
CYP2C19-inhibitor: | 0.518 | CYP2C19-substrate: | 0.595 |
CYP2C9-inhibitor: | 0.707 | CYP2C9-substrate: | 0.825 |
CYP2D6-inhibitor: | 0.088 | CYP2D6-substrate: | 0.565 |
CYP3A4-inhibitor: | 0.915 | CYP3A4-substrate: | 0.17 |
Clearance (CL): | 5.595 | Half-life (T1/2): | 0.459 |
hERG Blockers: | 0.246 | Human Hepatotoxicity (H-HT): | 0.751 |
Drug-inuced Liver Injury (DILI): | 0.573 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.944 | Maximum Recommended Daily Dose: | 0.995 |
Skin Sensitization: | 0.475 | Carcinogencity: | 0.02 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.97 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004119 | 0.838 | D0D7KC | 0.228 | ||||
ENC006133 | 0.818 | D0Z1FX | 0.220 | ||||
ENC003718 | 0.802 | D01JUF | 0.216 | ||||
ENC004120 | 0.710 | D0S0LZ | 0.207 | ||||
ENC004369 | 0.670 | D0Q1MS | 0.207 | ||||
ENC004370 | 0.655 | D06CWH | 0.203 | ||||
ENC004243 | 0.655 | D0WE3O | 0.198 | ||||
ENC003955 | 0.636 | D0SP3D | 0.198 | ||||
ENC004544 | 0.623 | D0FX2Q | 0.198 | ||||
ENC004918 | 0.623 | D0VA0I | 0.198 |